Antitumor activities of IL-12 and mechanisms of action.
Shurin
M R
MR
Biologic Therapeutics Program, University of Pittsburgh Cancer Institute, Pa., USA. mshu@med.pitt.edu
Esche
C
C
Péron
J M
JM
Lotze
M T
MT
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D015316:Genetic Therapy; D006801:Humans; D018664:Interleukin-12 / Q000235:genetics / Q000502:physiology* / Q000627:therapeutic use*; D009369:Neoplasms / Q000628:therapy
D000970:Antineoplastic Agents; D018664:Interleukin-12